DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on May 19, 2006; DOI: 10.1124/dmd.106.009498


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
dmd.106.009498v1
34/8/1376    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diani-Moore, S.
Right arrow Articles by Rifkind, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diani-Moore, S.
Right arrow Articles by Rifkind, A. B.


Received for publication January 27, 2006.
Revised April 29, 2006.
Accepted for publication May 12, 2006.

Induction of CYP1A and CYP2 mediated archidonic acid epoxidation and suppression of 20-HETE by imidazole derivatives including the aromatase inhibitor vorozole

Silvia Diani-Moore 1, Fotini Papachristou 1, Erin Labitzke 1, Arleen B. Rifkind 1*

1 Weill Medical College of Cornell University

* Address correspondence to: E-mail: arifkind{at}med.cornell.edu

Abstract

Cytochrome P450 enzymes metabolize the membrane lipid arachidonic acid to stable biologically active epoxides (EETs) and 20-HETE. These products have cardiovascular activity, primarily acting as vasodilators and vasoconstrictors, respectively. EET formation can be increased by the prototype CYP1A or CYP2 inducers, TCDD or phenobarbital, respectively. We report here that imidazole derivative drugs: the antihelminthics, albendazole and thiabendazole, the proton pump inhibitor, omeprazole, the thromboxane synthase inhibitor, benzylimidazole, and the aromatase (CYP19) inhibitor vorozole (R76713, racemate and R83842, (+) enantiomer) increased hepatic microsomal EET formation in a chick embryo model. Albendazole increased EETs by transcriptional induction of CYP1A5 and the others by combined induction of CYP1A5 and CYP2H, the avian orthologs of mammalian CYP1A2 and CYP2B, respectively. All inducers increased formation of the four EET regioisomers , but TCDD and albendazole had preference for 5,6-EET and PB and omeprazole for 14,15-EET. Vorozole, benzylimidazole and TCDD also suppressed 20-HETE formation. Vorozole was a remarkably effective and potent inducer of multiple hepatic CYPs at a dose range which overlapped its inhibition of ovarian aromatase. Increased CYP1A activity in mouse Hepa 1-6 and human HepG2 cells by vorozole and other imidazole derivatives demonstrated applicability of the findings to mammalian cells. The findings suggest that changes in CYP-dependent arachidonic acid metabolism may be a new source of side for drugs that induce CYP1A or CYP2. They demonstrate further that in vivo induction of multiple hepatic CYPs produces additive increases in AA epoxygenase activity and can occur concurrently with inhibition of ovarian aromatase activity.


Key words: arachidonic acid metabolism, CYP induction, CYP1A, CYP2B, eicosanoids, liver microsomes, chick embryo cytochrome P450, aromatase inhibitors, imidazole drugs


This article has been cited by other articles:


Home page
Toxicol SciHome page
S. P. Jones and S. W. Kennedy
Chicken Embryo Cardiomyocyte Cultures--A New Approach for Studying Effects of Halogenated Aromatic Hydrocarbons in the Avian Heart
Toxicol. Sci., May 1, 2009; 109(1): 66 - 74.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.